Evaluation of an online cognitive-behavioral therapy for insomnia and anxiety in older adults

Online cognitive-behavioral therapy (CBT) for insomnia and anxiety in older adults: a pilot study using e-SPACE, a multidomain web platform for health promotion

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN15338211

Enrollment

Registered

2021-12-13

Start date

2021-07-01

Completion date

Unknown

Last updated

2026-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Older adults with insomnia or anxiety symptoms. Mental and Behavioural Disorders

Interventions

Participants will be divided using a stratified (sex and use of medication) randomization method using an online tool. Updated 24/01/2022: Participants will be divided using a stratified (Geriatric A

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Current inclusion criteria as of 24/01/2022: 1. Aged =65 years 2. Insomnia Severity Index score >7 3. Ability to read and understand French 4. Reliable internet access 5. Ability to use a smartphone, tablet, or computer Previous inclusion criteria: 1. Aged =65 years 2. Mild symptoms of insomnia (Insomnia Severity Index score >8) or anxiety (Generalized Anxiety Disorder 7 score >5) 3. Ability to read and understand French 4. Reliable internet access 5. Ability to use a smartphone, tablet, or computer

Exclusion criteria

Exclusion criteria: 1. Currently hospitalized or expected to require hospital admission within 3 months 2. Suicidal thoughts 3. Uncorrected and severe hearing or vision impairment 4. Diagnosis of major neurocognitive disorder or bipolar disorder

Design outcomes

Primary

Measure	Time frame
Current primary outcome measures: 1. User satisfaction, defined as the level of comfort felt by the user when using the program and what the user thinks about different functionalities, measured using an adapted version of the System Usability Scale (SUS) at 8 weeks 2. User acceptance, defined as the extent to which the user is eager to adopt the web-based solution in the future, measured using an adapted version of the Technology Acceptance Model-2 (TAM-2) questionnaire at 8 weeks Previous primary outcome measures: 1. User efficiency, defined as the time for task completion and frequency of clicks on the wrong button, collected through the platform during the 8-week intervention 2. User satisfaction, defined as the level of comfort felt by the user when using the program and what the user thinks about different functionalities, measured using an adapted version of the System Usability Scale (SUS) at 8 weeks 3. User acceptance, defined as the extent to which the user is eager to adopt the web-based solution in the future, measured using an adapted version of the Technology Acceptance Model-2 (TAM-2) questionnaire at 8 weeks	—

Measure

Time frame

Current primary outcome measures: 1. User satisfaction, defined as the level of comfort felt by the user when using the program and what the user thinks about different functionalities, measured using an adapted version of the System Usability Scale (SUS) at 8 weeks 2. User acceptance, defined as the extent to which the user is eager to adopt the web-based solution in the future, measured using an adapted version of the Technology Acceptance Model-2 (TAM-2) questionnaire at 8 weeks Previous primary outcome measures: 1. User efficiency, defined as the time for task completion and frequency of clicks on the wrong button, collected through the platform during the 8-week intervention 2. User satisfaction, defined as the level of comfort felt by the user when using the program and what the user thinks about different functionalities, measured using an adapted version of the System Usability Scale (SUS) at 8 weeks 3. User acceptance, defined as the extent to which the user is eager to adopt the web-based solution in the future, measured using an adapted version of the Technology Acceptance Model-2 (TAM-2) questionnaire at 8 weeks

—

Secondary

Measure	Time frame
Current secondary outcome measures as of 24/01/2022: Intervention effectiveness measured using the following: 1. Sleep efficiency measured using sleep diaries at baseline and 8 weeks 2. Insomnia measured using the insomnia severity index (ISI) at baseline and 8 weeks 3. Anxiety measured using the Geriatric Anxiety Inventory (GAI) at baseline and 8 weeks Previous secondary outcome measures: Intervention effectiveness measured using the following: 1. Sleep efficiency measured using sleep diaries at baseline and 8 weeks 2. Insomnia measured using the insomnia severity index (ISI) at baseline and 8 weeks 3. Anxiety measured using the Geriatric Anxiety Inventory (GAI) and Generalised Anxiety Disorder Assessment (GAD-7) at baseline and 8 weeks	—

Measure

Time frame

Current secondary outcome measures as of 24/01/2022: Intervention effectiveness measured using the following: 1. Sleep efficiency measured using sleep diaries at baseline and 8 weeks 2. Insomnia measured using the insomnia severity index (ISI) at baseline and 8 weeks 3. Anxiety measured using the Geriatric Anxiety Inventory (GAI) at baseline and 8 weeks Previous secondary outcome measures: Intervention effectiveness measured using the following: 1. Sleep efficiency measured using sleep diaries at baseline and 8 weeks 2. Insomnia measured using the insomnia severity index (ISI) at baseline and 8 weeks 3. Anxiety measured using the Geriatric Anxiety Inventory (GAI) and Generalised Anxiety Disorder Assessment (GAD-7) at baseline and 8 weeks

—

Countries

Canada

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: May 22, 2026